semaglutide and other weight loss medications (wegovy) for GLP-1 Weight Loss Medication Guide:

You can use them instead of your insurance, or if you pay cash for your prescriptions

Perivascular spaces in the context of cerebral small-vessel disease Cerebral small-vessel disease commonly accompanies aging and is frequently identified on MRI through a constellation of features, including small subcortical infarcts, lacunes, white matter hyperintensities, enlarged PVS, cerebral microbleeds, and global brain atrophy

The Purest Glutathione Available

Restricting carbohydrates to less than 20 grams per day, as recommended in the first phase of the keto diet, can result in ketosis

"The messaging has been derailed from this being a medical breakthrough to a celebrity short-term weight-loss drug

Semaglutide reduced systolic blood pressure by 3.3 mm Hg, high-sensitivity C-reactive protein by 37.8%, and improved lipid profilesall achieved on top of high baseline rates of evidence-based cardiovascular therapies (90% on statins, 86% on antiplatelet agents).[1] These pleiotropic effects likely contribute to cardiovascular risk reduction through mechanisms distinct from adiposity changes, supporting the reconceptualization of GLP-1 receptor agonists as cardiovascular disease-modifying agents rather than simply weight-loss medications